Kros JM - Search Results

1

Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomas.

Bralten LB, Nouwens S, Kockx C, Erdem L, Hoogenraad CC, Kros JM, Moorhouse MJ, Sillevis Smitt PA, van der Spek P, van Ijcken W, Stubbs A, French PJ. Bralten LB, et al. Among authors: kros jm. PLoS One. 2011;6(7):e22000. doi: 10.1371/journal.pone.0022000. Epub 2011 Jul 7. PLoS One. 2011. PMID: 21760942 Free PMC article.

2

Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.

Rosso SM, van Dekken H, Krishnadath KK, Alers JC, Kros JM. Rosso SM, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 1997 Oct;56(10):1125-31. doi: 10.1097/00005072-199710000-00006. J Neuropathol Exp Neurol. 1997. PMID: 9329456

3

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates.

Driesse MJ, Vincent AJ, Sillevis Smitt PA, Kros JM, Hoogerbrugge PM, Avezaat CJ, Valerio D, Bout A. Driesse MJ, et al. Among authors: kros jm. Gene Ther. 1998 Aug;5(8):1122-9. doi: 10.1038/sj.gt.3300695. Gene Ther. 1998. PMID: 10326036

4

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.

Luider TM, Kros JM, Sillevis Smitt PA, van den Bent MJ, Vecht CJ. Luider TM, et al. Among authors: kros jm. Electrophoresis. 1999 Apr-May;20(4-5):1087-91. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<1087::AID-ELPS1087>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10344289

5

Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity.

Driesse MJ, Esandi MC, Kros JM, Avezaat CJ, Vecht C, Zurcher C, van der Velde I, Valerio D, Bout A, Sillevis Smitt PA. Driesse MJ, et al. Among authors: kros jm. Gene Ther. 2000 Aug;7(16):1401-9. doi: 10.1038/sj.gt.3301250. Gene Ther. 2000. PMID: 10981667

6

Proteomics in primary brain tumors.

Zheng PP, Kros JM, Sillevis-Smitt PA, Luider TM. Zheng PP, et al. Among authors: kros jm. Front Biosci. 2003 Jan 1;8:d451-63. doi: 10.2741/1008. Front Biosci. 2003. PMID: 12456299 Review.

7

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.

van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM. van den Bent MJ, et al. Among authors: kros jm. Cancer. 2003 Mar 1;97(5):1276-84. doi: 10.1002/cncr.11187. Cancer. 2003. PMID: 12599236 Free article.

8

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.

Zheng PP, Luider TM, Pieters R, Avezaat CJ, van den Bent MJ, Sillevis Smitt PA, Kros JM. Zheng PP, et al. Among authors: kros jm. J Neuropathol Exp Neurol. 2003 Aug;62(8):855-62. doi: 10.1093/jnen/62.8.855. J Neuropathol Exp Neurol. 2003. PMID: 14503641

9

Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature.

Zheng PP, Sieuwerts AM, Luider TM, van der Weiden M, Sillevis-Smitt PA, Kros JM. Zheng PP, et al. Among authors: kros jm. Am J Pathol. 2004 Jun;164(6):2217-28. doi: 10.1016/S0002-9440(10)63778-9. Am J Pathol. 2004. PMID: 15161654 Free PMC article.

10

Low-molecular weight caldesmon as a potential serum marker for glioma.

Zheng PP, Hop WC, Sillevis Smitt PA, van den Bent MJ, Avezaat CJ, Luider TM, Kros JM. Zheng PP, et al. Among authors: kros jm. Clin Cancer Res. 2005 Jun 15;11(12):4388-92. doi: 10.1158/1078-0432.CCR-04-2512. Clin Cancer Res. 2005. PMID: 15958622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters